Serviços Personalizados
Journal
Artigo
Indicadores
- Citado por SciELO
- Acessos
Links relacionados
- Citado por Google
- Similares em SciELO
- Similares em Google
Compartilhar
Revista Médica de Risaralda
versão impressa ISSN 0122-0667
Resumo
SANCHEZ HERNANDEZ, Verónica; MORALES PEREZ, Marlen e OSORIO ESPINOZA, Angélica. Polypharmacy for patients with chronic-degenerative diseases in a remote community, Puebla- México. Revista médica Risaralda [online]. 2022, vol.28, n.2, pp.127-138. Epub 27-Dez-2022. ISSN 0122-0667. https://doi.org/10.22517/25395203.25046.
Objective:
To determine if patients with chronic degenerative diseases between 50-90 years of age have polypharmacy and drug interactions, at the Huajoyuca Health Center of Palacios, between June 2018-June 2019.
Methodology:
A descriptive, observational, non-experimental, statistical, retrospective, cross-sectional, unicentric research was carried out. The sample consisted of 56 files according to the inclusion criteria. Data were analyzed according to descriptive statistics and frequency histograms.
Results:
The mean age is 67.11 ± 9.6 years. There was a higher prevalence of polypharmacy in the 60-69 age range. Due to excessive medication consumption, women make up 82 percent of those affected. Patients with chronic-degenerative disorders are the most likely to have polypharmacy, and those with comorbid conditions even more, it was observed that the consumption and frequency of medications per patient is 4.08 ± 1.56 medications. The top drugs consumed daily are metformin (17.41%), hydrochlorothiazide (12.05%), B vitamin, acetylsalicylic acid glibenclamide with (11.16%), losartan (8.03%), enalapril (6.69%), captopril (4.91 %). 38 patients with (68%) had minor polypharmacy, 17 patients with (30%) had major polypharmacy, and 1 patient with (2%), had excess polypharmacy.
Conclusion:
In order from highest to lowest, patients with type 2 diabetes mellitus have minor polypharmacy, unlike hypertensive and dyslipidemic patients. The gender most affected by polypharmacy is the female with 82% vs. 18% the male gender of the population studied.
Palavras-chave : Diabetes Mellitus type 2; Polypharmacy; Chronic Diseases; Dyslipidemia; Systemic Arterial Hypertension.